FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Naoko Sueoka

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Objects

Co-author Network

Publications

TOP 3
Naoko Sueoka; Akemi Sato; Hidetaka Eguchi; Kazutoshi Komiya; Toru Sakuragi; Masahiro Mitsuoka; Toshimi Satoh; Shinichiro Hayashi; Kei Nakachi; Eisaburo Sueoka
Mutation profile of EGFR gene detected by denaturing high-performance liquid chromatography in Japanese lung cancer patients.
Keisuke Aoe; Akio Hiraki; Takehiro Tanaka; Kenichi Gemba; Koji Taguchi; Tomoyuki Murakami; Naoko Sueoka; Toshiaki Kamei; Hiroshi Ueoka; Kazuro Sugi; Tadashi Yoshino; Takumi Kishimoto
Expression of vascular endothelial growth factor in malignant mesothelioma.
Akio Hiraki; Tomoyuki Murakami; Keisuke Aoe; Eisaburo Sueoka; Naoko Sueoka; Koji Taguchi; Toshiaki Kamei; Kazuro Sugi; Hiroshi Ueoka; Takumi Kishimoto
Heterogeneous nuclear ribonucleoprotein B1 expression in malignant mesothelioma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Naoko Sueoka (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Naoko Sueoka; Akemi Sato; Hidetaka Eguchi; Kazutoshi Komiya; Toru Sakuragi; Masahiro Mitsuoka; Toshimi Satoh; Shinichiro Hayashi; Kei Nakachi; Eisaburo Sueoka
Mutation profile of EGFR gene detected by denaturing high-performance liquid chromatography in Japanese lung cancer patients.
Journal of cancer research and clinical oncology 2007;133(2):93-102.
2006: Keisuke Aoe; Akio Hiraki; Takehiro Tanaka; Kenichi Gemba; Koji Taguchi; Tomoyuki Murakami; Naoko Sueoka; Toshiaki Kamei; Hiroshi Ueoka; Kazuro Sugi; Tadashi Yoshino; Takumi Kishimoto
Expression of vascular endothelial growth factor in malignant mesothelioma.
Anticancer research 2006;26(6C):4833-6.
2006: Akio Hiraki; Tomoyuki Murakami; Keisuke Aoe; Eisaburo Sueoka; Naoko Sueoka; Koji Taguchi; Toshiaki Kamei; Kazuro Sugi; Hiroshi Ueoka; Takumi Kishimoto
Heterogeneous nuclear ribonucleoprotein B1 expression in malignant mesothelioma.
Cancer science 2006;97(11):1175-81.
2006: Noriyasu Fukushima; Toshimi Satoh; Naoko Sueoka; Akemi Sato; Masaru Ide; Takashi Hisatomi; Nobuo Kuwahara; Rika Tomimasu; Naoko Tsuneyoshi; Noriko Funai; Masayuki Sano; Osamu Tokunaga; Eisaburo Sueoka
Clinico-pathological characteristics of p63 expression in B-cell lymphoma.
Cancer science 2006;97(10):1050-5.
2006: Keisuke Aoe; Akio Hiraki; Tomoyuki Murakami; Shinichi Toyooka; Narayan Shivapurkar; Adi F Gazdar; Naoko Sueoka; Koji Taguchi; Toshiaki Kamei; Hiroyasu Takeyama; Kazuro Sugi; Takumi Kishimoto
Infrequent existence of simian virus 40 large T antigen DNA in malignant mesothelioma in Japan.
Cancer science 2006;97(4):292-5.
2006: Megumi Senju; Naoko Sueoka; Akemi Sato; Kentaro Iwanaga; Yukinori Sakao; Shinji Tomimitsu; Masaki Tominaga; Koji Irie; Shinichiro Hayashi; Eisaburo Sueoka
Hsp90 inhibitors cause G2/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell lines.
Journal of cancer research and clinical oncology 2006;132(3):150-8.
2005: Kentaro Iwanaga; Naoko Sueoka; Akemi Sato; Shinichiro Hayashi; Eisaburo Sueoka
Heterogeneous nuclear ribonucleoprotein B1 protein impairs DNA repair mediated through the inhibition of DNA-dependent protein kinase activity.
Biochemical and biophysical research communications 2005;333(3):888-95.
2005: Akio Hiraki; Keisuke Aoe; Tomoyuki Murakami; Yuichi Nakamura; Koich Yamazaki; Naoko Sueoka; Koji Taguchi; Toshiaki Kamei; Tadashi Maeda; Hiroyasu Takeyama; Takumi Kishimoto; Masaharu Nishimura; Kazuro Sugi
Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma.
Oncology reports 2005;14(2):357-62.
2005: Eisaburo Sueoka; Naoko Sueoka; Kentaro Iwanaga; Akemi Sato; Kenji Suga; Shin-ichiro Hayashi; Kohei Nagasawa; Kei Nakachi
Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction.
Lung cancer (Amsterdam, Netherlands) 2005;48(1):77-83.
2004: Eisaburo Sueoka; Motohiro Yukitake; Kentaro Iwanaga; Naoko Sueoka; Tomoko Aihara; Yasuo Kuroda
Autoantibodies against heterogeneous nuclear ribonucleoprotein B1 in CSF of MS patients.
Annals of neurology 2004;56(6):778-86.
2003: Kentaro Iwanaga; Naoko Sueoka; Akemi Sato; Toru Sakuragi; Yukinori Sakao; Masaki Tominaga; Toru Suzuki; Yutaka Yoshida; Junko K-Tsuzuku; Tadashi Yamamoto; Shinichiro Hayashi; Kohei Nagasawa; Eisaburo Sueoka
Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer.
Cancer letters 2003;202(1):71-9.
2003: Masaki Tominaga; Naoko Sueoka; Koji Irie; Kentaro Iwanaga; Osamu Tokunaga; Shin-ichiro Hayashi; Kei Nakachi; Eisaburo Sueoka
Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1, and Ki-67.
Lung cancer (Amsterdam, Netherlands) 2003;40(1):45-53.
2002: Nobukazu Fujimoto; Naoko Sueoka; Eisaburo Sueoka; Sachiko Okabe; Masami Suganuma; Mine Harada; Hirota Fujiki
Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1.
International journal of oncology 2002;20(6):1233-9.
2001: Masami Suganuma; Miki Kurusu; S Okabe; Naoko Sueoka; M Yoshida; Y Wakatsuki; Hirota Fujiki
Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori.
Cancer research 2001;61(17):6356-9.
2001: Hirota Fujiki; Masami Suganuma; Sachiko Okabe; Eisaburo Sueoka; Naoko Sueoka; N Fujimoto; Y Goto; S Matsuyama; K Imai; K Nakachi
Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1.
Mutation research 2001;480-481():299-304.
2001: S Okabe; N Fujimoto; Naoko Sueoka; Masami Suganuma; Hirota Fujiki
Modulation of gene expression by (-)-epigallocatechin gallate in PC-9 cells using a cDNA expression array.
Biological & pharmaceutical bulletin 2001;24(8):883-6.
2001: Naoko Sueoka; Masami Suganuma; Eisaburo Sueoka; S Okabe; S Matsuyama; K Imai; K Nakachi; Hirota Fujiki
A new function of green tea: prevention of lifestyle-related diseases.
Annals of the New York Academy of Sciences 2001;928():274-80.
2001: Eisaburo Sueoka; Naoko Sueoka; Y Goto; S Matsuyama; H Nishimura; M Sato; S Fujimura; H Chiba; Hirota Fujiki
Heterogeneous nuclear ribonucleoprotein B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia.
Cancer research 2001;61(5):1896-902.
2000: S Matsuyama; Y Goto; Naoko Sueoka; Y Ohkura; Y Tanaka; K Nakachi; Eisaburo Sueoka
Heterogeneous nuclear ribonucleoprotein B1 expressed in esophageal squamous cell carcinomas as a new biomarker for diagnosis.
Japanese journal of cancer research : Gann 2000;91(6):658-63.
2000: Masami Suganuma; Eisaburo Sueoka; Naoko Sueoka; S Okabe; Hirota Fujiki
Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-alpha expression.
BioFactors (Oxford, England) 2000;13(1-4):67-72.
2000: K Inoue; S Okabe; Eisaburo Sueoka; Naoko Sueoka; T Tabei; M Suganuma
The role of interleukin-6 in inhibition of lung metastasis in subcutaneous tumor-bearing mice.
Oncology reports 2000;7(1):69-73.
1999: Masami Suganuma; S Okabe; Naoko Sueoka; Eisaburo Sueoka; S Matsuyama; K Imai; K Nakachi; Hirota Fujiki
Green tea and cancer chemoprevention.
Mutation research 1999;428(1-2):339-44.
1999: Eisaburo Sueoka; Y Goto; Naoko Sueoka; Y Kai; T Kozu; Hirota Fujiki
Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers.
Cancer research 1999;59(7):1404-7.
1999: Masami Suganuma; S Okabe; Y Kai; Naoko Sueoka; Eisaburo Sueoka; Hirota Fujiki
Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9.
Cancer research 1999;59(1):44-7.
1998: Eisaburo Sueoka; Naoko Sueoka; Y Kai; S Okabe; Masami Suganuma; K Kanematsu; T Yamamoto; Hirota Fujiki
Anticancer activity of morphine and its synthetic derivative, KT-90, mediated through apoptosis and inhibition of NF-kappaB activation.
Biochemical and biophysical research communications 1998;252(3):566-70.
1998: Hirota Fujiki; Masami Suganuma; S Okabe; Naoko Sueoka; A Komori; Eisaburo Sueoka; T Kozu; Y Tada; K Suga; K Imai; K Nakachi
Cancer inhibition by green tea.
Mutation research 1998;402(1-2):307-10.
1998: Eisaburo Sueoka; Naoko Sueoka; S Okabe; A Komori; M Suganuma; T Kozu; H Fujiki
Tumourigenicity of MTG8, a leukaemia-related gene, in concert with v-Ha-ras gene in BALB/3T3 cells.
British journal of haematology 1998;101(4):737-42.
1998: S Okabe; Naoko Sueoka; A Komori; Masami Suganuma; Y Endo; K Shudo; Hirota Fujiki
Twist form of teleocidin derivatives is active in in vivo tumor promotion by (-)-benzolactam-V8-310.
Biological & pharmaceutical bulletin 1998;21(5):465-8.
1998: Naoko Sueoka; Eisaburo Sueoka; Y Miyazaki; S Okabe; M Kurosumi; S Takayama; Hirota Fujiki
Molecular pathogenesis of interstitial pneumonitis with TNF-alpha transgenic mice.
Cytokine 1998;10(2):124-31.
1997: Eisaburo Sueoka; Naoko Sueoka; S Okabe; T Kozu; A Komori; T Ohta; Masami Suganuma; S J Kim; In Kyoung Lim; Hirota Fujiki
Expression of the tumor necrosis factor alpha gene and early response genes by nodularin, a liver tumor promoter, in primary cultured rat hepatocytes.
Journal of cancer research and clinical oncology 1997;123(8):413-9.
1996: Hirota Fujiki; Masami Suganuma; S Okabe; A Komori; Eisaburo Sueoka; Naoko Sueoka; T Kozu; Y Sakai
Japanese green tea as a cancer preventive in humans.
Nutrition reviews 1996;54(11 Pt 2):S67-70.
1996: Naoko Sueoka; Eisaburo Sueoka; S Okabe; Hirota Fujiki
Anti-cancer effects of morphine through inhibition of tumour necrosis factor-alpha release and mRNA expression.
Carcinogenesis 1996;17(11):2337-41.
1996: T Kozu; Eisaburo Sueoka; S Okabe; Naoko Sueoka; A Komori; Hirota Fujiki
In vitro catalytic activities of DNA/RNA chimeric hammerhead ribozymes against AML1-MTG8 mRNA, a fused gene transcript in acute myeloid leukemia with t(8;21).
Biochimie 1996;78(11-12):1067-73.
1996: T Kozu; Eisaburo Sueoka; S Okabe; Naoko Sueoka; A Komori; Hirota Fujiki
Designing of chimeric DNA/RNA hammerhead ribozymes to be targeted against AML1/MTG8 mRNA.
Journal of cancer research and clinical oncology 1996;122(4):254-6.